Redwood Pharma to attend the ARVO annual meeting and BIO-Europe (Fall) in 2022
Redwood Pharma will be attending two of the leading international conferences in ophthalmology and biotechology during 2022. The goals of the conferences will be to explore partnering interest in the Company’s two dry eye programs, RP501 and RP101, as well as explore development collaborations where the IntelliGel drug delivery platform can be used. · ARVO (Virtual) – May 11-12 · BIO-Europe (Fall, Leipzig Germany) – Oct. 24 – 26 To set up a meeting with Redwood Pharma, please contact:Martin Vidaeus – CEO, Phone: +46 70-232 29 29Email: martin.vidaeus@redwoodpharma.com RP501